Federal Register / Vol. 87, No. 102 / Thursday, May 26, 2022 / Notices 32055 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be collected 

can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Annual Reporting Requirement for 

Manufacturers of Listed Chemicals. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Form number: N/A. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Diversion Control 

Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): None. 

Abstract: Pursuant to 21 U.S.C. 

830(b)(2) and 21 CFR 1310.05(d), 

manufacturers of listed chemicals must 

file annual reports of manufacturing, 

inventory, and use data for the listed 

chemicals they manufacture. These 

reports allow DEA to monitor the 

volume and availability of domestically 

manufactured listed chemicals, which 

may be subject to diversion for the illicit 

production of controlled substances. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: Each respondent for this 

information collection completes one 

response per year. DEA estimates there 

are 50 respondents, and that each 

response takes 0.25 hours to complete. 

6. An estimate of the total public 

burden (in hours) associated with the 

proposed collection: DEA estimates this 

collection takes a total of 12.5 annual 

burden hours. 

If additional information is required, 

please contact: Melody Braswell, 

Department Clearance Officer, United 

States Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, Suite 3E.405B, 

Washington, DC 20530. 

Dated: May 23, 2022. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–11310 Filed 5–25–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0033] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection Report of Mail 

Order Transactions 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Department of Justice, 

Drug Enforcement Administration 

(DEA), will be submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 60 days until July 

25, 2022. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments, especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Diversion 

Control Division, Drug Enforcement 

Administration; Mailing Address: 8701 

Morrissette Drive, Springfield, Virginia 

22152; Telephone: (571) 776–2265. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be collected 

can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other forms of 

information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: Report 

of Mail Order Transactions. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Form Number: None. The Department of 

Justice component is the Drug 

Enforcement Administration, Diversion 

Control Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Affected public (Primary): 

Business or other for-profit. Affected 

public (Other): None. 

Abstract: The Drug Enforcement 

Administration (DEA) collects 

information regarding mail order 

transactions conducted between a 

person regulated by the agency and a 

nonregulated person (that is, someone 

who does not further distribute the 

product) involving the chemicals 

ephedrine, pseudoephedrine, and 

phenylpropanolamine. Transactions 

must use, or attempt to use, the United 

States Postal Service or any private or 

commercial carrier. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: 

Number of 

annual 

respondents 

Number of 

responses per 

year 

Number of 

annual 

responses 

Average time 

per response 

(hours) 

Total annual 

hours 

Mail Order Reports .............................................................. 22 12 264 1 264 

Total .............................................................................. 22 N/A 264 N/A 264 


khammond on DSKJM1Z7X2PROD with NOTICES
32056 Federal Register / Vol. 87, No. 102 / Thursday, May 26, 2022 / Notices 

6. An estimate of the total public 

burden (in hours) associated with the 

proposed collection: The DEA estimates 

that this collection takes 264 annual 

burden hours. 

If additional information is required, 

please contact: Melody Braswell, 

Department Clearance Officer, United 

States Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, Suite 3E.405B, 

Washington, DC 20530. 

Dated: May 23, 2022. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–11320 Filed 5–25–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0008] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection; Application for 

Procurement Quota for Controlled 

Substance and for Ephedrine, 

Pseudoephedrine, and 

Phenylpropanolamine; DEA Form 250 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Department of Justice, 

Drug Enforcement Administration 

(DEA), will be submitting the following 

information collection request to the 

Office of Management and Budget for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until June 27, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be collected 

can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Application for Procurement Quota for 

Controlled Substance and for 

Ephedrine, Pseudoephedrine, and 

Phenylpropanolamine. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Form 250. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Diversion Control 

Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): None. 

Abstract: Pursuant to 21 U.S.C. 826 

and 21 CFR 1303.12(b) and 1315.32, any 

person who desires to use, during the 

next calendar year, any basic class of 

controlled substances listed in 

schedules I or II, or the List I chemicals 

ephedrine, pseudoephedrine, or 

phenylpropanolamine for purposes of 

manufacturing must apply on DEA 

Form 250 for a procurement quota for 

such class or List I chemical. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The DEA estimates 344 

respondents complete 3,066 DEA Form 

250 applications annually, and that each 

form requires 0.5 hours to complete. 

6. An estimate of the total public 

burden (in hours) associated with the 

proposed collection: The DEA estimates 

this collection takes a total of 1,533 

annual burden hours. 

If additional information is required, 

please contact: Melody Braswell, 

Department Clearance Officer, United 

States Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, Suite 3E.405B, 

Washington, DC 20530. 

Dated: May 23, 2022. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–11318 Filed 5–25–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0047] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection; Application for 

Import Quota for Ephedrine, 

Pseudoephedrine, and 

Phenylpropanolamine; DEA Form 488 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Department of Justice, 

Drug Enforcement Administration 

(DEA), will be submitting the following 

information collection request to the 

Office of Management and Budget for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until June 27, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 


khammond on DSKJM1Z7X2PROD with NOTICES